Camptosar

Active Ingredient(s): Irinotecan
FDA Approved: * June 14, 1996
Pharm Company: * PHARMACIA AND UPJOHN
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Camptosar Overview

Irinotecan, sold under the brand name Camptosar among others, is a medication used to treat colon cancer, and small cell lung cancer.[1] For colon cancer it is used either alone or with fluorouracil.[1] For small cell lung cancer it is used with cisplatin.[1] It is given by slow injection into a vein.[1] Common side effects include diarrhea, vomiting, bone marrow suppression, hair loss, shortness of breath, and fever.[1&a...

Read more Camptosar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Irinotecan

Recent Camptosar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Irinotecan
  • Injection: 100mg/5ml (20mg/ml), 20mg/ml, 300mg/15ml (20mg/ml), 40mg/2ml (20mg/ml)
  • Injection, Liposomal: 43mg/10ml (4.3mg/ml)
  • Vial: 43mg/10ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Camptosar: (2 results)

Sorted by National Drug Code
  • 0009-1111 Camptosar 20 mg/ml Intravenous Injection, Solution by Pharmacia and Upjohn Company
  • 0009-7529 Camptosar 20 mg/ml Intravenous Injection, Solution by Pharmacia and Upjohn Company

Other drugs which contain Irinotecan or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA